Methods of reducing angiogenesis

US7652038B2 · kind B2 · utility

Assignee

• The Board of Trustees of the Leland Stanford Jr. University · US

Inventors

• John Cooke · Palo Alto, US
• Christopher Heeschen · Frankfurt am Main, DE
• Michael Weis · Munich, DE

Key dates

• Filing date: May 9, 2008
• Grant date: Jan 26, 2010
• Expiry date: May 9, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides methods of reducing angiogenesis in an individual. The methods generally involve administering to the individual an effective amount of a nicotinic acetyl choline receptor antagonist. The methods are useful to treat conditions associated with or resulting from angiogenesis, particularly pathological angiogenesis. The invention further provides methods of treating a condition associated with or resulting from angiogenesis.